AstraZeneca's combo lung disease therapy fails to win FDA approval

October 01, 2019  Unknown  No comments

The U.S. Food and Drug Administration declined to approve AstraZeneca Plc's combination therapy to treat smoker's lung, the drugmaker said on Tuesday.



from Reuters: U.S. https://ift.tt/2o2KiKe

Posted in:

0 comments:

Post a Comment